CNBC's "Fast Money" Crude’s Crumble… And Why A Market Goldilocks Scenario Is Still In Play 12/16/25
4 snips
Dec 16, 2025 Crude oil prices tumble as WTI falls below $55, sparking discussions about the energy sector's struggles and stock performance. Experts debate how low oil could go, with predictions hitting $40–$35 amidst implications for producers. The panel also explores the potential benefits of disinflation and Fed easing on investment portfolios. Meanwhile, Pfizer faces challenges with declining COVID revenues and competitive pressures in obesity drugs. Activist rumors swirl around Comcast, and talks of airline mergers pick up steam.
AI Snips
Chapters
Transcript
Episode notes
Lower Oil Helps Macro But Hurts Some Stocks
- Lower oil can help disinflation and may push the Fed toward cuts, benefiting risk assets broadly.
- But oil services and exploration firms suffer in a prolonged decline even if broader macro is constructive.
Commodity Oddities Signal Broader Weakness
- Historic commodity anomalies emerged: nat gas down sharply and silver worth more than a barrel of oil in decades.
- Those readings signal underlying economic weakness and supply gluts, not just temporary dislocation.
Stay Measured On Pfizer Opportunities
- Don't panic on Pfizer despite COVID-era decline; consider valuation and potential obesity-drug upside from acquisitions.
- Stick with long positions if you believe acquisition-driven catalysts will materialize, per panel discussion.